BioNTech SE (BNTX) EBITDA Margin Growth (3y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -11,254.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11,254.00 |
| Sep 30, 2025 | -7,207.00 |
| Jun 30, 2025 | -23,209.00 |
| Mar 31, 2025 | -213,835.00 |
| Dec 31, 2024 | 441,808.00 |
| Sep 30, 2024 | -6,259.00 |
| Jun 30, 2024 | -286,994.00 |
| Mar 31, 2024 | -326,375.00 |
| Dec 31, 2023 | -3,512.00 |
| Sep 30, 2023 | -25,917.00 |
| Jun 30, 2023 | -52,961.00 |
| Mar 31, 2023 | -16,283.00 |
| Sep 30, 2022 | -5,967.00 |
| Jun 30, 2022 | -11,651.00 |
| Mar 31, 2022 | -9,305.00 |
| Dec 31, 2021 | 8,486.00 |
| Sep 30, 2021 | 7,760.00 |